Bonifacio, Ritchel L.
HRN: 06-74-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2024
CEFTRIAXONE 1G (VIAL)
11/10/2024
11/16/2024
IVT
2g
OD
Acute Pyelonephritis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes